Gilead Sciences, Inc. - Inflammation
Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need. Gilead’s dedicated Inflammation R&D team is focused on improving therapeutic options for the treatment of multiple inflammatory conditions, including Crohn’s disease (CD) and ulcerative colitis (UC). With the help of dedicated clinicians who manage these conditions, we are pursuing a comprehensive clinical trial program evaluating novel agents with the goal of advancing the care of patients suffering from UC and CD.
DDW Tracks Microbiome in Gastrointestinal and Liver Diseases, Inflammatory Bowel Diseases, Liver Diseases and Transplantation, Esophageal Diseases, Stomach and Small Bowel Disorders, Colorectal Diseases, Functional GI and Motility Disorders, Pancreatic Diseases, Biliary Tract Diseases
Does your company only service US attendees? No
Is your company a new exhibiting company? Yes